Tracking Outcomes by Secondary Diagnoses in Patients Prescribed Intravenous Lidocaine for Chronic Pain

International Spine, Pain and Performance Center

Summary

The purpose of this research is to gather data on the performance and functionality of IV lidocaine infusions prescribed to patients with chronic pain.

Eligibility

Age range: 18–80 years
Sex: All
Healthy volunteers: Not specified

Detailed criteria

Inclusion Criteria: * Age 18-80 years * Patients with chronic pain syndrome * Patients that have been prescribed and scheduled to receive an intravenous lidocaine infusion treatment Exclusion Criteria: * Not willing to comply with the requirements of the study

Interventions

Drug
Lidocaine IV
Intravenous (IV) infusion of lidocaine. Administered to adult patients with chronic pain.

Location

International Spine Pain & Performance Center
Washington D.C., District of Columbia
vbrownlee@isppcenter.com